Peter Elliott serves as Executive at Sirtris Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Peter Elliott has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 27, 2008 involved exercising options for 21,428 shares valued at $23.6K.
Peter Elliott currently holds 234,618 shares of Sirtris Pharmaceuticals, Inc. (SIRT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Elliott has been a net neutral trader of SIRT stock. They have purchased $0 and sold $0 worth of shares.
Peter Elliott's most recent insider trade was on May 27, 2008, when they sold 21,428 shares at $1.10 per share.
Get notified when new Form 4 filings are submitted
| 74,404 |
| $0.42 |
| Discretionary |
| Jan 2, 2008 | SIRT | $0 | Award | 42,500 | $N/A | Discretionary |
| Jan 2, 2008 | SIRT | $0 | Award | 42,500 | $N/A | Discretionary |
| May 29, 2007 | SIRT | $0 | Conversion | 2,834 | $N/A | Discretionary |